Improved adenoviral vectors and uses thereof

Details for Australian Patent Application No. 2005293568 (hide)

Owner Crucell Holland B.V. Beth Israel Deaconess Medical Center Inc.

Inventors Havenga, Menzo Jans Emco; Barouch, Dan

Agent Davies Collison Cave

Pub. Number AU-B-2005293568

PCT Pub. Number WO2006/040330

Priority 60/618,469 13.10.04 US; 60/697,724 08.07.05 US; 04105005.5 13.10.04 EP

Filing date 12 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 28 October 2010

International Classifications

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

5 April 2007 PCT application entered the National Phase

  PCT publication WO2006/040330 Priority application(s): WO2006/040330

28 October 2010 Application Accepted

  Published as AU-B-2005293568

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293570-Fatty acid esters of alkanolamines and their use as softening agents

2005293560-Binding molecules for treatment and detection of cancer